CRLF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.374000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.113400E-01
Normal-vs-Stage2
4.494800E-01
Normal-vs-Stage3
4.035000E-01
Normal-vs-Stage4
5.020600E-01
Stage1-vs-Stage2
6.093000E-01
Stage1-vs-Stage3
8.529600E-01
Stage1-vs-Stage4
2.176800E-01
Stage2-vs-Stage3
5.753400E-01
Stage2-vs-Stage4
6.400200E-01
Stage3-vs-Stage4
3.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.403800E-01
Normal-vs-AfricanAmerican
5.131200E-01
Normal-vs-Asian
3.491000E-01
Caucasian-vs-AfricanAmerican
4.405800E-01
Caucasian-vs-Asian
6.887800E-02
AfricanAmerican-vs-Asian
4.638000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.312800E-01
Normal-vs-Female
4.456600E-01
Male-vs-Female
6.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.369800E-01
Normal-vs-Age(41-60Yrs)
4.776000E-01
Normal-vs-Age(61-80Yrs)
4.211000E-01
Normal-vs-Age(81-100Yrs)
4.042800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.512000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.766200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.172400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.028500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.750400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.736200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.199200E-01
Normal-vs-Daily Drinker
3.784200E-01
Normal-vs-Weekly Drinker
4.004000E-01
Normal-vs-Occasional Drinker
4.366400E-01
Normal-vs-Social Drinker
4.259200E-01
Non Drinker-vs-Daily Drinker
3.464000E-01
Non Drinker-vs-Weekly Drinker
7.157400E-01
Non Drinker-vs-Occasional Drinker
7.288200E-01
Non Drinker-vs-Social Drinker
9.322600E-01
Daily Drinker-vs-Weekly Drinker
6.441600E-01
Daily Drinker-vs-Occasional Drinker
1.305780E-01
Daily Drinker-vs-Social Drinker
3.332400E-01
Weekly Drinker-vs-Occasional Drinker
4.443600E-01
Weekly Drinker-vs-Social Drinker
6.788800E-01
Occasional Drinker-vs-Social Drinker
8.139400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.926000E-01
Normal-vs-Grade 2
3.096300E-02
Normal-vs-Grade 3
1.959580E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.094400E-01
Grade 1-vs-Grade 3
4.172600E-01
Grade 1-vs-Grade 4
2.926000E-01
Grade 2-vs-Grade 3
7.300800E-01
Grade 2-vs-Grade 4
3.096300E-02
Grade 3-vs-Grade 4
1.959580E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.482600E-01
Normal-vs-NonDiabetic
4.069000E-01
Diabetic-vs-NonDiabetic
2.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.034600E-01
Normal-vs-NoPancreatitis
4.235600E-01
Pancreatitis-vs-NoPancreatitis
4.591200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.308400E-01
Normal-vs-N1
4.462600E-01
N0-vs-N1
6.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.115800E-01
Normal-vs-TP53-NonMutant
4.338600E-01
TP53-Mutant-vs-TP53-NonMutant
5.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
